Two Health IT Veterans Join XSOLIS' Board
Summary
NASHVILLE, Tenn., Nov. 20, 2019 /PRNewswire/ -- XSOLIS, the company using artificial intelligence to redesign utilization management between payers and providers, today announced two additions to its Board of Directors: Doug Ghertner and George Lazenby, IV. Mr. Ghertner currently serves as CEO of IVX Health, a national provider of infusion and injection therapy for individuals with complex chronic conditions. Prior to joining IVX Health, he served as CEO of Change Healthcare from 2011 to 2014 before its acquisition by Emdeon in 2014, at which point he remained on as Chief Sales Officer until 2017. "The energy and expertise Doug and George bring to bear are exciting for our organization," said Joan Butters, CEO and co-founder of XSOLIS. Partnering with some of the most forward-thinking healthcare organizations across the nation, XSOLIS transforms the utilization management process between payers and providers: XSOLIS analytics and artificial intelligence form a common framework for objective, holistic determinations of medical necessity and automate much of the administrative burden within the review process.
